PHILADELPHIA, May 22, 2023 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq:…
PHILADELPHIA, May 22, 2023 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq:…
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM…
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM…
IND submission for ONCR-021 still planned for mid-2023, subject to receipt of additional funding Ended…
IND submission for ONCR-021 still planned for mid-2023, subject to receipt of additional funding Ended…
TERN-601 (oral GLP-1) program in obesity on track to initiate Phase 1 clinical trial in…
TERN-601 (oral GLP-1) program in obesity on track to initiate Phase 1 clinical trial in…
Achieved “Last Patient Out” milestone in Phase 3 clinical program evaluating DFD-29 in May 2023…
Achieved “Last Patient Out” milestone in Phase 3 clinical program evaluating DFD-29 in May 2023…
9 poster presentations and 3 abstracts publications reinforce Galapagos’ commitment to immunology and the rheumatoid…
AIM nanoparticle approach can identify select EBV-specific T cell defects in patients with multiple sclerosis…
OLD GREENWICH, Conn.–(BUSINESS WIRE)–Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced that at its…
Divests Non-Core Businesses in a Company Reset to Maximize Opportunities in the Esports and E-simulator…
Delivered profitability with ROE at 2% in real terms; Tier 1 Capital Ratio at 14.7%…
Veeam recognizes partners who have demonstrated outstanding performance and expertise in delivering Data Protection and…
Q1 2023 Revenue Increases 217% to $10.7 Million MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM:…
VALLEY FORGE, Pa.–(BUSINESS WIRE)–#AmeriGas–UGI Corporation (NYSE: UGI) announced today that its subsidiaries, AmeriGas Partners, L.P….
Direct delivery of imatinib to the lungs in nonclinical species demonstrated increased lung exposure compared…
Direct delivery of imatinib to the lungs in nonclinical species demonstrated increased lung exposure compared…